Apr 14, 2014 by Dave Williamson and Michael DouglassThe Supreme Court Will Decide the Fate of a BlockbusterTeva's day in court is coming.
Apr 14, 2014 by Dave Williamson and Michael DouglassEli Lilly's $3 Billion MistakeA jury rules against Eli Lilly and partner Takeda with steep punative penalties
Apr 14, 2014 by Dave WilliamsonIs This the Answer to Expensive Hepatitis-C Cures?A dangerous new competitor for Gilead's miracle hepatitis-C drug, Sovaldi, may be on its way to market.
Apr 7, 2014 by Dave Williamson2014's Most Shocking TakeoverThe Verdict is in: Questcor Pharmaceuticals Bulls Win, Bears Lose
Apr 7, 2014 by Dave WilliamsonMannKind vs. Idenix: Better Biotech BuyWhat's the better buy in biotech today?
Apr 6, 2014 by Dave Williamson and Michael DouglassIs the FDA Poised to Crack Down on E-Cigs?Electronic cigarettes are loosely regulated, but it looks like that is about to change.
Apr 6, 2014 by Dave Williamson and Michael DouglassThe Newest IPO Craze: Big Data Meets Big HealthThe large IMS Health Holdings Inc IPO highlights the surging investor popularity of healt-hcare IT companies.
Apr 6, 2014 by Dave Williamson and Michael DouglassPartner Signed! Is Amarin's Turnaround Beginning?Amarin Corporation plc (ADR) signed Japan's Kowa Pharmaceuticals as a marketing partner for Vascepa.
Apr 3, 2014 by Dave WilliamsonAmgen, Inc. Pays GlaxoSmithKline plc (ADR) to Go AwayAmgen says goodbye to its Big Pharma partner.
Apr 3, 2014 by Dave Williamson and Michael DouglassDown 20%: Plummeting Pot Stock ScandalIs this crashing cannabinoid stock an isolated incident, or a warning sign to investors in marijuana stocks, in general?
Apr 2, 2014 by Dave WilliamsonGreatest Drug Launch Ever Bulldozes DoubtersGilead blows the doubters out of the water, as Sovaldi sees massive adoption rates.
Apr 2, 2014 by Dave WilliamsonWhen Harsh Medicare Cuts Are Cause for CelebrationThe Medicare cuts were big, but not as big as the market had feared, which is cause for celebration for Myriad.
Apr 2, 2014 by Dave WilliamsonMannKind's Dominating Win Annihilates the ShortsOne of the biggest winners on the entire market today sends the short sellers packing.
Apr 2, 2014 by Dave WilliamsonIntuitive's Good NewsHere's why shares of Intuitive Surgical delighted investors on Tuesday.
Apr 2, 2014 by Dave WilliamsonObamacare: The AftermathThe official end date for enrollment in Obamacare this year has passed. How do things look now that the dust is settling?
Mar 31, 2014 by Dave WilliamsonDown 70%: Is Prana Biotechnology Ltd. a Buy?Shares of Prana were absolutely crushed today, after a phase 2 failure for its Alzheimer's drug.
Mar 31, 2014 by Dave WilliamsonObamacare Enrollment's Dramatic Finish*Obamacare enrollment officially ends today ... but not really.
Mar 31, 2014 by Dave WilliamsonBig Pharma Failure = Biotech Takeover?Today's big winner in the biotech space is Endocyte, because of a bit of schadenfreude.
Mar 31, 2014 by Dave Williamson and Michael DouglassSpecial Situation Alert: Time to Buy a Biotech Breakup?Baxter announced it is splitting into two separate businesses
Mar 30, 2014 by Dave Williamson and Michael DouglassWhich Biotech Blow-Up Is a Bad-News Buy?These two biotechs bombed bad on Thursday. Which one would make an interesting buy today?
